6 Years & 100 Episodes: What in the World Has Happened?

In this special 100th episode of The Weekly Bioanalysis, hosts John Perkins and Dominic Warrino are joined on camera by KCAS Bio CEO John Bucksath and Chief Commercial Officer Amy Mize to celebrate a major milestone. Together, they reflect on the podcast's origins during the uncertainty of the COVID-19 pandemic and how it evolved into a trusted industry platform over the past six years. The conversation explores the remarkable growth of KCAS Bio, from a single local laboratory to a globally recognized bioanalytical partner with an expanding international presence. Along the way, the group discusses the role The Weekly Bioanalysis has played in strengthening industry connections, sharing scientific insights, and helping tell the KCAS Bio story. It's a fitting look back at the people, conversations, and achievements that helped shape both the podcast and the company over its first 100 episodes. “The Weekly Bioanalysis” is a podcast dedicated to discussing bioanalytical news, tools and services related to the pharmaceutical, biopharmaceutical and biomarker industries. Every month, KCAS Bio will bring you another 60 minutes (or so) of friendly banter between our two finest Senior Scientific Advisors as they chat over coffee and discuss what they’ve learned about the bioanalytical world the past couple of weeks. “The Weekly Bioanalysis” is brought to you by KCAS Bio.KCAS Bio is a progressive growing contract research organization of well over 250 talented and dedicated individuals with growing operations in Kansas City, Doylestown, PA, and Lyon, France, where we are committed to serving our clients and improving health worldwide. Our experienced scientists provide stand-alone bioanalytical services to the pharmaceutical, biopharmaceutical, animal health and medical device industries.